home / stock / rani / rani news


RANI News and Press, Rani Therapeutics Holdings Inc. From 07/14/25

Stock Information

Company Name: Rani Therapeutics Holdings Inc.
Stock Symbol: RANI
Market: NASDAQ
Website: ranitherapeutics.com

Menu

RANI RANI Quote RANI Short RANI News RANI Articles RANI Message Board
Get RANI Alerts

News, Short Squeeze, Breakout and More Instantly...

RANI - Penny Power Plays - July 14, 2025

2025-07-14 11:22:32 ET DENVER, Colo., Jul 14, 2025 ( 247marketnews.com )- In today’s edition of Penny Power Plays , we’re rounding up key momentum and updates from several familiar names in our penny stock watchlist Full Alliance Group (OTC:FAGI) just stepp...

RANI - Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery 

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present precl...

RANI - Rani Therapeutics files to sell 13.16M shares of Class A common stock by selling shareholders

2025-07-03 14:59:24 ET More on Rani Therapeutics Seeking Alpha’s Quant Rating on Rani Therapeutics Historical earnings data for Rani Therapeutics Financial information for Rani Therapeutics Read the full article on Seeking Alpha For further det...

RANI - Rani Therapeutics Announces Research Agreement with Chugai

- Research agreement is evaluating feasibility of applying Rani’s oral delivery technology to Chugai’s antibodies against undisclosed targets - SAN JOSE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “...

RANI - Rani Therapeutics GAAP EPS of -$0.22, revenue of $0.17M

2025-05-14 11:05:22 ET More on Rani Therapeutics Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript Rani Therapeutics Holdings, Inc. 2024 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Rani Therapeutics ...

RANI - Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

- Announced preclinical data demonstrating the bioequivalence of RT-114, a bispecific GLP-1/GLP-2 receptor agonist (PG-102), delivered orally via the RaniPill® capsule, to subcutaneous administration of PG-102 - - Phase 1 study for RT-114 for the treatment of obesity expected to init...

RANI - Expected US Company Earnings on Monday, May 12th, 2025

Redwire Corporation (RDW) is expected to report $-0.2 for Q1 2025 Organigram Global Inc. (OGI) is expected to report $-0.03 for Q2 2025 Inter & Co. Inc. (INTR) is expected to report $0.12 for Q1 2025 Pervasip Corp (PVSP) is expected to report for quarter end 2025-02-28 Maui La...

RANI - Expected US Company Earnings on Monday, May 5th, 2025

National Health Investors Inc. (NHI) is expected to report $1.13 for Q1 2025 Palomar Holdings Inc. (PLMR) is expected to report $1.45 for Q1 2025 Weave Communications Inc. (WEAV) is expected to report $-0.11 for Q1 2025 First National Bank Alaska (FBAK) is expected to report for Q1 20...

RANI - RANI - Historical Price Movements Surrounding Earnings

2025-05-04 18:48:27 ET Rani Therapeutics Holdings, Inc. (RANI) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 2.83%. The average open to low on the day of earnings was -5.84%. The avera...

RANI - RANI - Historical Earnings Price Analysis

2025-05-04 18:43:28 ET Rani Therapeutics Holdings, Inc. (RANI) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in RANI stock price following earnings has averaged ±3.05% , with a median o...

Previous 10 Next 10